Table 4.

Bone biomarker outcomes at baseline and after 4 month in FES-T assisted walking and CONV groups. The values are shown as mean (standard deviation)

Group	Bone Marker		N	Baseline	4 Month	P-value
FES-T	CTX ng/mL	Group	15	0.26 (0.15)	0.24 (0.17)	0.05*
		Male	12	0.28 (0.15)	0.31 (0.17)	0.11**
		Female	3	0.17 (0.17)	0.22 (0.18)	0.06**
	Osteocalcin µg/mL	Group	15	16.70 (6.51)	17.77 (6.23)	0.02*
		Male	12	17.7 (6.80)	18.87 (6.40)	0.50**
		Female	3	12.5 (3.04)	13.40 (3.20)	0.06**
	Sclerostin pmol/L	Group	15	52.87 (16.78)	54.34 (20.13)	0.11**
		Male	12	53.27 (16.46)	54.55 (20.93)	0.24**
		Female	3	51.30 (21.81)	53.50 (20.66)	0.06**
CONV	CTX ng/mL	Group	11	0.24 (0.21)	0.27 (0.18)	0.26**
		Male	6	0.36 (0.23)	0.35 (0.20)	0.50**
		Female	5	0.10 (0.02)	0.16 (0.10)	0.04**
	Osteocalcin µg/mL	Group	11	20.10 (8.33)	20.74 (8.62)	0.28*
		Male	6	25.38 (7.53)	25.36 (7.97)	0.46**
		Female	5	13.76 (3.25)	15.20 (6.00)	0.25**
	Sclerostin pmol/L	Group	10	58.28 (12.43)	61.06 (13.52)	0.19*
		Male	6	63.60 (10.78)	67.26 (15.04)	0.17**
		Female	5	52.96 (12.68)	54.86 (9.46)	0.25**

*One-sided P-value was reported.

**Non-parametric test was used.

N values are described in Fig. 1.